Those that have read my earlier posts will know that I have been saying that EGX is no ordinary biotech minnow and the high profile board is not there for the tea and biscuits at meeting so check out todays announcement.
EGX has done a deal with a major pharmar - GlaxoSmithKline in the case of this announcemnt. This is an income bearing deal on research and royalties on products launch. As I have said before, if you are not into this stock you don't like money.
EGX Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
